A detailed history of American Portfolios Advisors transactions in Penumbra Inc stock. As of the latest transaction made, American Portfolios Advisors holds 715 shares of PEN stock, worth $173,316. This represents 0.01% of its overall portfolio holdings.

Number of Shares
715
Holding current value
$173,316
% of portfolio
0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$120.36 - $205.88 $86,057 - $147,204
715 New
715 $136 Million
Q2 2022

Mar 20, 2023

BUY
$116.09 - $227.33 $19,387 - $37,964
167 Added 23.36%
882 $110 Million
Q1 2022

Mar 21, 2023

BUY
$187.51 - $283.98 $64,503 - $97,689
344 Added 48.11%
1,059 $235 Million
Q4 2021

Mar 21, 2023

SELL
$238.08 - $288.0 $5,475 - $6,624
-23 Reduced 3.22%
692 $199 Million
Q3 2021

Mar 22, 2023

SELL
$250.72 - $291.24 $15,043 - $17,474
-60 Reduced 8.39%
655 $175 Million
Q2 2021

Mar 22, 2023

SELL
$235.0 - $310.7 $35,720 - $47,226
-152 Reduced 21.26%
563 $154 Million
Q1 2021

Mar 22, 2023

SELL
$175.6 - $291.43 $29,500 - $48,960
-168 Reduced 23.5%
547 $148 Million
Q4 2020

Mar 22, 2023

SELL
$174.98 - $272.83 $36,045 - $56,202
-206 Reduced 28.81%
509 $89.1 Million
Q3 2020

Mar 22, 2023

SELL
$185.27 - $238.73 $43,908 - $56,579
-237 Reduced 33.15%
478 $92.9 Million
Q1 2020

Mar 24, 2023

SELL
$124.34 - $193.76 $27,976 - $43,596
-225 Reduced 31.47%
490 $79.1 Million
Q4 2019

Mar 24, 2023

SELL
$134.81 - $177.8 $34,915 - $46,050
-259 Reduced 36.22%
456 $74.9 Million
Q3 2019

Mar 24, 2023

SELL
$131.82 - $183.4 $17,532 - $24,392
-133 Reduced 22.58%
456 $61.3 Million
Q2 2019

Mar 24, 2023

SELL
$124.65 - $167.39 $15,705 - $21,091
-126 Reduced 17.62%
589 $94.2 Million
Q1 2019

Mar 24, 2023

BUY
$115.84 - $160.31 $13,205 - $18,275
114 Added 22.05%
631 $92.8 Million
Q4 2018

Mar 24, 2023

SELL
$113.42 - $156.48 $22,457 - $30,983
-198 Reduced 27.69%
517 $63.2 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.18B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.